Skip to main
VRXA

VRXA P/E Ratio

P/E Ratio as of Jun 12, 2026: 93.37

Average104.55
Median104.55
Minimum93.37
Maximum115.73
93.37
The P/E ratio for VRXA is 93.37 as of Jun 12, 2026. This represents a increase of 868.57% compared to its 12-month average P/E ratio of 9.64. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Veraxa Biotech AG P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Veraxa Biotech AG’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Veraxa Biotech AG to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

VRXA P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 11, 2026$24.79115.73

VRXA End of Year P/E Ratio

DateP/E ratioChange
202693.37

FAQs About Veraxa Biotech AG (VRXA) P/E ratio

The latest P/E ratio of VRXA is 93.37, as of Jun 12, 2026. This is calculated based on its current stock price and earnings per share (EPS).

Veraxa Biotech AG’s last 12-month average P/E ratio is 9.64, compared to its current P/E ratio of 93.37. This reflects a increase of 868.57%.

Veraxa Biotech AG’s current P/E ratio of 93.37 is higher than its last 12-month average P/E of 9.64. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Veraxa Biotech AG’s average P/E ratio over the last 3 years is 3.21. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Veraxa Biotech AG’s average P/E ratio over the last 5 years is 1.93. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Veraxa Biotech AG (VRXA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.